AmSurg EVP Sells 1.5k Shares

Phillip A. Clendenin, the executive vice president of Amsurg, has sold 1,500 shares in the company at an average price of $43, according to a report by Ticker Report.

The entire transaction, legally disclosed in a filing with Securities & Exchange Commission, was a total of $64,500.

Piper Jaffray Cos. has also increased Amsurg's target price from $36 to $42. Analysts with Deutsche Bank have raised their target price for the company from $39 to $45.

More Articles on Transactions and Valuation Issues:
Medical Facilities Corporation Announces October Dividend
What to Consider Before Selling an ASC
Key Observations on ASC Transactions in 2013

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast